An Epidemiological Study of Acute Coronary Syndromes in The Greek Population. The TARGET Study

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Acute Coronary Syndromes

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01061086
NIS-CGR-DUM-2009/1

Details and patient eligibility

About

This is a multicenter, 2-phase observational study of acute coronary syndromes (ACS) in Greece, designed to provide real world data on the risk factors of patients presenting to a hospital emergency department with an index event, as well as to depict the current management practices and outcomes of these clinical conditions in Greece.

Enrollment

418 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of an ACS (STEMI, NSTEMI, UA).
  • Informed Consent

Exclusion criteria

  • Involvement in the planning and conduct of the study (applies to both AstraZeneca staff and staff at the study sites).
  • Participation in other clinical study in period between the index event and 6- month follow-up assessment with the exception of registering in registries or surveys not influencing the management of the ACS.

Trial design

418 participants in 1 patient group

1
Description:
Patients over 18 years old admitted to the hospital with Acute Coronary Syndrome.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems